Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

(HZNP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Goldman Sachs Upgrades Horizon Therapeutics to Buy From Neutral; Price Target is $168

11/19/2021 | 05:23am EST


ę MT Newswires 2021
All news about HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
01/25Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
AQ
01/24Horizon Therapeutics Enrolls First Patient in Trial of Idiopathic Pulmonary Fibrosis Tr..
MT
01/24Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
BU
01/24Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
CI
01/11Horizon Therapeutics plc Submits Supplemental Biologics License for the Concomitant Use..
AQ
01/10Horizon Therapeutics Seeks to Expand Indication for Uncontrolled Gout Medicine Krystexx..
MT
01/10Horizon Therapeutics plc Submits Supplemental Biologics License for the Concomitant Use..
BU
01/062022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, P..
AQ
01/06Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Dev..
BU
01/06Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Dev..
CI
More news
Analyst Recommendations on HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
More recommendations
Financials (USD)
Sales 2021 3 200 M - -
Net income 2021 351 M - -
Net Debt 2021 1 151 M - -
P/E ratio 2021 61,3x
Yield 2021 -
Capitalization 20 718 M 20 718 M -
EV / Sales 2021 6,83x
EV / Sales 2022 5,19x
Nbr of Employees 1 805
Free-Float 97,8%
Chart HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Duration : Period :
Horizon Therapeutics Public Limited Company Technical Analysis Chart | HZNP | IE00BQPVQZ61 | MarketScreener
Technical analysis trends HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 91,34 $
Average target price 140,50 $
Spread / Average Target 53,8%
EPS Revisions
Managers and Directors
Timothy P. Walbert Chairman, President & Chief Executive Officer
Paul W. Hoelscher Chief Financial Officer & Executive Vice President
Jeffrey W. Sherman CMO, Executive VP-Development & Regulatory Affairs
Jeffrey D. Kent Executive VP-Medical Affairs & Outcomes Research
Karin Rosen Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-15.24%19 813
JOHNSON & JOHNSON-0.28%449 095
ROCHE HOLDING AG-6.46%307 637
PFIZER, INC.-9.62%299 559
ABBVIE INC.0.42%240 379
NOVO NORDISK A/S-12.29%219 960